These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15311888)

  • 1. [New 2004 guidelines of the Breast Organ Committee of AGO].
    Krankenpfl J; 2004; 42(3-4):81. PubMed ID: 15311888
    [No Abstract]   [Full Text] [Related]  

  • 2. American symposium looks at new antineoplastic drug.
    Korcok M
    Can Med Assoc J; 1985 Jul; 133(1):66-7. PubMed ID: 3891062
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiotoxicity of epirubicin versus doxorubicin: cost and clinical results.
    Ventura GJ
    J Clin Oncol; 2005 Apr; 23(12):2873; author reply 2873-4. PubMed ID: 15838014
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of breast cancer. Investigational treatment.
    Jones SE
    Ariz Med; 1974 Mar; 31(3):197-8. PubMed ID: 4362033
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
    Fiore J; Kemeny N; Raymond V; Young C
    Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of pharmorubicin in cancer of the breast].
    Ass NIa; Borisov VI
    Sov Med; 1986; (10):36-9. PubMed ID: 3544240
    [No Abstract]   [Full Text] [Related]  

  • 7. Doxorubicin in combination chemotherapy for breast cancer: a preliminary report.
    Ward HW
    Br J Clin Pract; 1974 Apr; 28(4):137-8. PubMed ID: 4841023
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
    Booth BW; Korzun AH; Weiss RB; Ellison RR; Budman D; Khojasteh A; Wood W
    Cancer Treat Rep; 1986 Oct; 70(10):1247-8. PubMed ID: 3530455
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II evaluation of piperazinedione in metastatic breast carcinoma.
    Palmer RL; Samal BA; Vaughn CB; Tranum BL
    Cancer Treat Rep; 1977 Dec; 61(9):1711-2. PubMed ID: 340035
    [No Abstract]   [Full Text] [Related]  

  • 10. Pegylated liposomal doxorubicin in elderly patients with metastatic breast cancer.
    Minisini AM; Andreetta C; Fasola G; Puglisi F
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):331-42. PubMed ID: 18366282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of 4'-epi-doxorubicin in advanced breast cancer.
    Campora E; Nobile MT; Sertoli MR; Rosso R
    Cancer Treat Rep; 1984 Oct; 68(10):1285-6. PubMed ID: 6597003
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy.
    Buchholz TA; Tu X; Ang KK; Esteva FJ; Kuerer HM; Pusztai L; Cristofanilli M; Singletary SE; Hortobagyi GN; Sahin AA
    Cancer; 2005 Aug; 104(4):676-81. PubMed ID: 15981280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin for metastatic breast cancer: time for a change?
    Muggia F
    Cancer Invest; 2003; 21(6):967-8. PubMed ID: 14735701
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy-induced subacute lupus erythematosus.
    Guhl G; Diaz-Ley B; García-García C; Fraga J; Garcia-Diez A
    Lupus; 2009 Aug; 18(9):859-60. PubMed ID: 19578115
    [No Abstract]   [Full Text] [Related]  

  • 15. [Liposomal doxorubicin in patients with breast cancer and concomitant cardiovascular diseases - interdisciplinary expert opinion].
    Szmit S; Filipiak KJ; Litwiniuk M; Opolski G; Wysocki P; Zaborska B; Krzakowski M
    Kardiol Pol; 2016; 74(9):1031-6. PubMed ID: 27654476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
    Willson JK; Knuiman MW; Skeel RT; Wolter JM; Pandya KJ; Falkson G; Chang YC
    Cancer Treat Rep; 1986 Oct; 70(10):1237-8. PubMed ID: 3530452
    [No Abstract]   [Full Text] [Related]  

  • 17. Doxorubicin-induced ventricular arrhythmia treated by implantation of an automatic cardioverter-defibrillator.
    Rudzinski T; Ciesielczyk M; Religa W; Bednarkiewicz Z; Krzeminska-Pakula M
    Europace; 2007 May; 9(5):278-80. PubMed ID: 17383986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathological absence of cardiotoxicity after liposomal doxorubicin.
    Jones RL; Berry GJ; Rubens RD; Miles DW
    Lancet Oncol; 2004 Sep; 5(9):575-7. PubMed ID: 15337488
    [No Abstract]   [Full Text] [Related]  

  • 19. Esorubicin in refractory metastatic carcinoma of the breast: a Northern California Oncology Group Study.
    Carlson RW; Billingham ME; Kohler M; Johnson FD; Doroshow JH; Torti FM
    Cancer Treat Rep; 1987 Apr; 71(4):427-8. PubMed ID: 3548961
    [No Abstract]   [Full Text] [Related]  

  • 20. [Improving prognosis with docetaxel and monoclonal antibodies].
    Krankenpfl J; 2005; 43(7-10):233. PubMed ID: 16515303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.